SciClone Reports Second Quarter 2017 Financial Results

FOSTER CITY, Calif., Aug. 9, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today reported financial results for the quarter ended June 30, 2017.

Revenues: In the second quarter of 2017, SciClone reported revenues of $44.5 million, compared to $39.0 million for the same period in 2016.

GAAP Diluted EPS: In the second quarter of 2017, SciClone reported GAAP diluted earnings per share of $0.23, compared to $0.12 for the same period in 2016.

Back to news